Your browser doesn't support javascript.
loading
HER2 positivity as a biomarker for poor prognosis and unresponsiveness to anti-EGFR therapy in colorectal cancer.
Huang, Wenbai; Chen, Yijiao; Chang, Wenju; Ren, Li; Tang, Wentao; Zheng, Peng; Wu, Qi; Liu, Tianyu; Liu, Yu; Wei, Ye; Xu, Jianmin.
Afiliación
  • Huang W; Department of General Surgery, Colorectal Cancer Center, Zhongshan Hospital, Fudan University, 180 Fenglin Road, Shanghai, People's Republic of China.
  • Chen Y; Department of General Surgery, Zhongshan Hospital, Fudan University, Shanghai, China.
  • Chang W; Department of General Surgery, Colorectal Cancer Center, Zhongshan Hospital, Fudan University, 180 Fenglin Road, Shanghai, People's Republic of China.
  • Ren L; Department of General Surgery, Zhongshan Hospital, Fudan University, Shanghai, China.
  • Tang W; Department of General Surgery, Colorectal Cancer Center, Zhongshan Hospital, Fudan University, 180 Fenglin Road, Shanghai, People's Republic of China.
  • Zheng P; Department of General Surgery, Zhongshan Hospital, Fudan University, Shanghai, China.
  • Wu Q; Shanghai Engineering Research Center of Colorectal Cancer Minimally Invasive, Shanghai, China.
  • Liu T; Department of General Surgery, Colorectal Cancer Center, Zhongshan Hospital, Fudan University, 180 Fenglin Road, Shanghai, People's Republic of China.
  • Liu Y; Department of General Surgery, Zhongshan Hospital, Fudan University, Shanghai, China.
  • Wei Y; Shanghai Engineering Research Center of Colorectal Cancer Minimally Invasive, Shanghai, China.
  • Xu J; Cancer Center, Zhongshan Hospital, Fudan University, Shanghai, China.
J Cancer Res Clin Oncol ; 148(4): 993-1002, 2022 Apr.
Article en En | MEDLINE | ID: mdl-34156520
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Colorrectales / Receptor ErbB-2 Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: J Cancer Res Clin Oncol Año: 2022 Tipo del documento: Article Pais de publicación: Alemania
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Colorrectales / Receptor ErbB-2 Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: J Cancer Res Clin Oncol Año: 2022 Tipo del documento: Article Pais de publicación: Alemania